Does Medicare cover Vascepa?
Yes — Medicare Part D and Medicare Advantage drug plans generally cover it, with brand Vascepa on a brand tier and generic icosapent ethyl typically on a much lower generic tier. Prior authorisation is common, and because the cardiovascular indication requires maximally tolerated statin therapy, a plan may ask for your statin history. Part D out-of-pocket costs are capped at $2,100 in 2026, and
Medicare Extra Help can bring a covered brand-name copay to about $12.65.
Which charity fund should I apply to for Vascepa?
It depends on your diagnosis, and the difference is substantial. TotalAssist covers Vascepa on two funds because its label has two indications. The Hypercholesterolemia fund was OPEN when we checked on August 26, 2026, paying $1,900 guaranteed up to $3,800. The Hypertriglyceridemia fund was closed but pays $3,300 guaranteed up to $6,600 — nearly double. If your recorded diagnosis is severe hypertriglyceridemia, that is the fund built for you and the one to set an alert on; if it is hypercholesterolemia, apply to the open fund now. TotalAssist gives one grant per condition, so this is about matching your diagnosis rather than collecting both.
Is there a Vascepa patient assistance program for people on Medicare?
No. Amarin's published support for Vascepa is a savings card for commercially insured patients and, for uninsured patients, a GoodRx discount arrangement — and no income-based program that supplies Vascepa free of charge. The savings card excludes Medicare outright: "Patients enrolled in Medicare, Medicaid, TRICARE, or similar federal or state prescription drug insurance programs are not eligible for this offer." So Amarin offers a Medicare beneficiary nothing, which is why the open TotalAssist fund and the generic carry this page.
Is there a generic for Vascepa?
Yes, and it is thoroughly established. DailyMed lists 31 labelled icosapent ethyl products across 21 distinct labelers, including Amneal, Apotex, Aurobindo, Camber and Dr. Reddy's. The federal TrumpRx site prices generic icosapent ethyl at $14.00 and carries no listing for brand Vascepa. Both TotalAssist funds list the generic alongside the brand, so switching would not cost you fund eligibility.
Is Vascepa the same as fish oil from the pharmacy shelf?
No, and it is worth being clear about, because the price difference makes the substitution tempting. Vascepa is a prescription medicine — the label describes it as "a lipid-regulating agent" containing "icosapent ethyl, an omega-3 fatty acid ethyl ester" — approved with specific indications and specific triglyceride thresholds behind them. Over-the-counter fish-oil supplements are not equivalent products and are not regulated the same way. If cost is the problem, generic icosapent ethyl at $14.00 is the substitution to ask your prescriber about, not a supplement.
Is Vascepa part of Medicare drug price negotiation?
No. CMS's selected-drug and Maximum Fair Price file has no Vascepa or icosapent ethyl row for initial price applicability year 2026, 2027 or 2028 — unsurprising for a medicine that already has generic competition, since the program selects drugs without it. Your cost is set by your plan's tier and cost-sharing, and above all by whether you are dispensed the brand or the generic. See
all prescription assistance options.